At a glance
- Originator Daiichi Pharmaceutical
- Class Antiallergics; Antiasthmatics; Antiulcers; Cytoprotectives; Small molecules
- Mechanism of Action Leukotriene receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Peptic ulcer
Most Recent Events
- 16 Feb 1995 Discontinued-II for Asthma in Germany (PO)
- 16 Feb 1995 Discontinued-II for Asthma in United Kingdom (PO)
- 16 Feb 1995 Discontinued-II for Asthma in USA (PO)